Product Images Rizatriptan Benzoate

COOH likely refers to the organic functional group known as a carboxyl group, which is made up of a carbon atom bonded to an oxygen atom with a double bond and a hydroxyl group (-OH) also attached to the carbon atom. This group is found in a variety of molecules, including amino acids and fatty acids.*

The table shows the estimated probability of a response to Rizatriptan benzoate tablets 5mg and 10mg. The percentage of response ranges from 0% to 100% within 20 hours post-dose. The probability of response decreases as time passes after dosing. The probability of response for the placebo group is 72% at 2 hours post-dose, which is higher than the response rate for both Rizatriptan benzoate tablet groups at that time.*

This is a graph showing the percentage of effectiveness along with confidence intervals (95% CI) of Rizatriptan Benzoate orally disintegrating tablets compared to a placebo. The graph displays the results at specific hours post-stage 2 dose, ranging from 0 to 20 hours.*

The text provides instructions on how to separate a blister unit from the blister pack. It advises to tear along the dotted lines until the unit is fully separated.*

This is a package of Rizatriptan Benzoate, USP tablets containing 7.265 mg of the compound, which is equivalent to 5 mg of rizatriptan per tablet. The package contains 18 unit dose tablets, packaged in 36 blisters, and comes with a circular with usage instructions for adults. The tablets should be stored in a controlled room temperature range of 20° to 25°C (68°F to 77°F) and in a child-resistant container. The package's NDC number is 51991-354-78, and it is distributed by Breckenridge Pharmaceutical, Inc. The manufacturer is Natco Pharma Limited, located in Kothur, India.*

This is a description of Rizatriptan Benzoate tablets for adults. Each tablet contains 14.53 mg of Rizatriptan Benzoate USP equivalent to 10 mg rizatriptan. The usual adult dosage is not available in the provided text, and the storage temperature is 20°C to 25°C (68°F to 77°F). This unit-dose package is child-resistant and should be kept out of reach of children. The manufacturer is Breckenridge Pharmaceutical, Inc. with NDC code 51991-355-78. The package contains 18-unit dose tablets (3x6 Blisters). The expiration date is not available, and the distribution code is M.LA64/MN/AP/OS/FR. The tablet was manufactured by NATCO PHARMA LIMITED in Kothur- 509 228, In.*